跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
stanniocalcin-1
首页
药物
stanniocalcin-1
stanniocalcin-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for treating pulmonary fibrosis using a pharmaceutical composition containing stanniocalcin 1 (STC1)
US 9060988 B2
申请人: OHKOUCHI SHINYA
优先权: 2011
US
2 件公开
Stanniocalcin-1 (STC-1) therapy for treatment of retinal diseases
US 9498517 B2
申请人: SCOTT & WHITE HEALTHCARE
优先权: 2015
US
STAT3 PHOSPHORYLATION INHIBITOR, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE AND CORONAVIRUS INFECTION
EP 4194004 A4
申请人: UNIV TOHOKU
优先权: 2020
EP
STANNIOCALCIN 2 (STC2) AND DERIVATIVES AS ANTI-DIABETIC AGENTS
WO 2026008015 A1
申请人: UNIV HONG KONG
优先权: 2024
WO
Application of STC-1 recombinant protein in preparation of medicine for treating myocardial infarction
CN 119896723 A
申请人: THE FOURTH AFFILIATED HOSPITAL OF XINJIANG MEDICAL UNIV
优先权: 2025
CN
药物
反馈